Oral contraceptives did not increase risk for flare in women with systemic lupus erythematosus: COMMENTARY

Denman, Michael
May 2006
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p75
Academic Journal
The article presents the author's views regarding a study about risk factors associated with the use of oral contraceptives (OCs) in women with systemic lupus erythematosus (SLE). The study provides evidence that OCs can safely be prescribed for patients with SLE. This form of contraception did not adversely affect disease course. However, the author is a bit skeptic about how combined OCs can now be prescribed to patients with SLE with complete equanimity and without any further monitoring.


Related Articles

  • Flares with OCs in nonsevere SLE: what's the risk?  // Reactions Weekly;1/7/2006, Issue 1083, p4 

    This article discusses research being done on the risk of systemic lupus erythematosus flares patients using oral contraceptives. It references a study by Bonnie L. Bermas published in the December 15, 2005 issue of the "New England Journal of Medicine." The effect of oral contraceptives on...

  • Oral contraceptives did not increase risk for flare in women with systemic lupus erythematosus.  // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p75 

    The article presents information on a study about risk factors associated with the use of oral contraceptives (OCs) in women with systemic lupus erythematosus (SLE). This study was conducted on 183 women having 18 to 39 years of age with inactive or stable active SLE. It was found that OC did...

  • Risk factors of vertebral fractures in women with systemic lupus erythematosus. Mendoza-Pinto, Claudia; García-Carrasco, Mario; Sandoval-Cruz, Hilda; Muñoz-Guarneros, Margarita; Esc#x00E1;rcega, Ricardo O.; Jiménez-Hernández, Mario; Munguía-Realpozo, Pamela; Sandoval-Cruz, Manuel; Delezé-Hinojosa, Margarita; López-Colombo, Aurelio; Cervera, Ricard // Clinical Rheumatology;May2009, Vol. 28 Issue 5, p579 

    The aim of the current study was to analyze the role of traditional and systemic lupus erythematosus (SLE)-related risk factors in the development of vertebral fractures. A cross-sectional study was performed in women with SLE attending a single center. A vertebral fracture was defined as a...

  • Deciphering autoimmune disease in women. D'Epiro, Nancy Walsh // Patient Care;4/15/2000, Vol. 34 Issue 7, p49 

    Discusses cellular and molecular activities of the immune system that contribute to autoimmune diseases in women. Immunologically-based treatments; Genetic and environmental factors; Focus on multiple sclerosis, scleroderma and systemic lupus erythematosus (SLE). INSETS: Characteristics of CDA...

  • Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus. Petri, Michelle; Kim, Mimi Y.; Kalunian, Kenneth C.; Grossman, Jennifer; Hahn, Bevra H.; Sammaritano, Lisa R.; Lockshin, Michael; Merrill, Joan T.; Belmont, H. Michael; Askanase, Anca D.; McCune, W. Joseph; Hearth-Holmes, Michelene; Dooley, Mary Anne; Von Feldt, Joan; Friedman, Alan; Tan, Mark; Davis, John; Cronin, Mary; Diamond, Betty; Mackay, Meggan // New England Journal of Medicine;12/15/2005, Vol. 353 Issue 24, p2550 

    Background: Oral contraceptives are rarely prescribed for women with systemic lupus erythematosus, because of concern about potential negative side effects. In this double-blind, randomized, noninferiority trial, we prospectively evaluated the effect of oral contraceptives on lupus activity in...

  • Chimerism in systemic lupus erythematosus—three hypotheses. I. C. L. Kremer Hovinga; M. Koopmans; E. de Heer; J. A. Bruijn; I. M. Bajema // Rheumatology;Feb2007, Vol. 46 Issue 2, p200 

    Systemic lupus erythematosus (SLE) is an immune-mediated disease characterized by the presence of autoantibodies and a wide array of clinical symptoms. Despite intensive research, the aetiology of SLE is still unknown and is probably multifactorial. Both genetic and environmental factors have...

  • LUPUS ERITEMATOSO SISTÉMICO Y COMPLICACIONES EN EL EMBARAZO. Díaz-Castro, Alexander // Revista Colombiana de Obstetricia y Ginecologia;2009, Vol. 60 Issue 1, p93 

    Background: as systemic lupus erythematosus (SLE) is a common disease in young women and does not affect fertility cases may usually be found in which a woman can be both pregnant and suffer from this disease at the same time. Even though prognosis has improved, SLE should still be considered as...

  • Epidemiologic studies of environmental agents and systemic autoimmune diseases. Mayes // Environmental Health Perspectives Supplements;Oct99 Supplement 5, Vol. 107, p743 

    Summarizes relevant case-control and cohort studies that investigated exogenous sex hormones and other environmental agents as putative risk factors for the development of autoimmune diseases. Exogenous sex hormones and the risk of developing systemic lupus erythematosus or scleroderma; Effects...

  • Systemic lupus erythematosus complicating autoimmune pulmonary alveolar proteinosis that was worsened by immunosuppressive therapy. Nagasawa, J; Kurasawa, K; Maezawa, R; Owada, T; Hanaoka, R; Fukuda, T // Lupus;Sep2013, Vol. 22 Issue 10, p1060 

    A 26-year-old Japanese woman developed autoimmune pulmonary alveolar proteinosis (PAP) during glucocorticoid therapy for systemic lupus erythematosus (SLE). Intensive immunosuppressive therapy worsened the PAP. De-escalation of immunosuppressive therapy improved the PAP. Autoimmune PAP is rarely...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics